Search

everythinglearnresearchcommunity

for

Search:↓

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Topical Ruxolitinib may safely treat severe hair loss.

Baricitinib improved hair loss and arthritis in a lupus patient.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Cyproterone acetate can effectively treat idiopathic hirsutism, but ethinyl oestradiol and lynoestrenol may not always reduce hair growth.

Patients were very satisfied with hair regrowth after taking ritlecitinib for alopecia areata.

Certain genetic variations can make people more likely to experience hair loss and low white blood cell count from azathioprine.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

Bupropion causes more hair loss than other antidepressants, with paroxetine causing the least.

St. John's wort increases finasteride metabolism, reducing its effectiveness; use caution when combining them.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

Monitor for early signs of myelosuppression, like hair loss, in patients on azathioprine to manage side effects.

Janus kinase inhibitors may help treat lichen planopilaris.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.

Ruxolitinib can cause a delayed skin reaction on the nose.

A new engineered treatment shows promise in curing heart fibrosis.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

Minocycline reduces acne rash, pyridoxine lowers hand-foot syndrome risk, and scalp cooling lessens hair loss from cancer treatments.

Topical sulfonylurea may reduce excessive hair growth caused by certain medications.

Albendazole treatment for echinococcosis can cause serious side effects and requires close monitoring.

Combination therapy with Finasteride is more effective than alpha-blocker alone for BPH symptoms in small prostate volume.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

A cystic fibrosis patient developed Cushing's syndrome from a drug interaction between itraconazole and inhaled budesonide.